Her-2 positive breast cancers depend on the growth protein Her2 for continued cancer growth. We have a few different treatments that can “turn off” this Her-2 growth protein. Frequently, we will use a combination of chemotherapy and Her-2 targeted medicine prior to surgery in Her-2 positive breast cancer patients. The goal is to get rid… Read more »
We use immunotherapy in many other cancer types to help increase the immune system’s ability to identify and attack cancer cells. For years, we have not been able to find a way that immunotherapy would benefit women with breast cancer. In a recent trial, women with untreated metastatic breast cancer were randomized to receive chemotherapy,… Read more »
Recently, results of the International Duration Evaluation of Adjuvant Chemotherapy (IDEA) trial were published. This study compared the efficacy of two different durations of chemotherapy after resection of stage III colon cancer: 3 months vs 6 months of chemotherapy with standard chemotherapy drugs, 5FU and oxaliplatin. The study showed only a very small benefit in… Read more »
